It has been a couple of month because the final earnings report for Common Well being Companies (UHS). Shares have added about 0.3% in that time-frame, outperforming the S&P 500.
Will the current constructive pattern proceed main as much as its subsequent earnings launch, or is Common Well being Companies due for a pullback? Earlier than we dive into how buyers and analysts have reacted as of late, let’s take a fast have a look at its most up-to-date earnings report with the intention to get a greater deal with on the vital catalysts.
How Have Estimates Been Shifting Since Then?
It seems, estimates overview have trended upward in the course of the previous month.
The consensus estimate has shifted 6.09% attributable to these adjustments.
VGM Scores
At present, Common Well being Companies has a terrific Development Rating of A, although it’s lagging a bit on the Momentum Rating entrance with a B. Charting a considerably comparable path, the inventory was allotted a grade of A on the worth aspect, placing it within the high quintile for this funding technique.
Total, the inventory has an mixture VGM Rating of A. In the event you aren’t targeted on one technique, this rating is the one you need to be all in favour of.
Outlook
Estimates have been trending upward for the inventory, and the magnitude of those revisions appears to be like promising. It comes with little shock Common Well being Companies has a Zacks Rank #2 (Purchase). We count on an above common return from the inventory within the subsequent few months.
Efficiency of an Business Participant
Common Well being Companies belongs to the Zacks Medical – Hospital business. One other inventory from the identical business, Tenet Healthcare (THC), has gained 3% over the previous month. Greater than a month has handed because the firm reported outcomes for the quarter ended December 2024.
Tenet reported revenues of $5.07 billion within the final reported quarter, representing a year-over-year change of -5.7%. EPS of $3.44 for a similar interval compares with $2.68 a 12 months in the past.
Tenet is predicted to publish earnings of $3.12 per share for the present quarter, representing a year-over-year change of -3.1%. During the last 30 days, the Zacks Consensus Estimate has modified +1%.
The general course and magnitude of estimate revisions translate right into a Zacks Rank #3 (Maintain) for Tenet. Additionally, the inventory has a VGM Rating of A.
Zacks’ Analysis Chief Names “Inventory Most More likely to Double”
Our staff of specialists has simply launched the 5 shares with the best likelihood of gaining +100% or extra within the coming months. Of these 5, Director of Analysis Sheraz Mian highlights the one inventory set to climb highest.
This high decide is among the many most progressive monetary companies. With a fast-growing buyer base (already 50+ million) and a various set of innovative options, this inventory is poised for large positive aspects. After all, all our elite picks aren’t winners however this one might far surpass earlier Zacks’ Shares Set to Double like Nano-X Imaging which shot up +129.6% in little greater than 9 months.
Free: See Our Top Stock And 4 Runners Up
Universal Health Services, Inc. (UHS) : Free Stock Analysis Report
Tenet Healthcare Corporation (THC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.
